{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:00:22Z","timestamp":1766516422716,"version":"3.48.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Schnitzler syndrome (SS) is a rare autoinflammatory disorder that presents with chronic urticarial rash, neutrophilic urticarial dermatosis, monoclonal IgG or IgM gammopathy, recurrent fever, joint and\/or bone pain and enlarged lymph nodes, spleen and\/or liver. Several cases in the literature have described patients with incomplete variants of SS that lack monoclonal gammopathy. This systematic review aims to analyse the current literature regarding the features of Schnitzler-like syndrome (SLS; i.e. patients with clinical features of SS but without the obligate Strasbourg criterion of monoclonal gammopathy) and their treatment outcomes; we also report our own case of a patient with SLS. A systematic search of MEDLINE, Embase, Scopus and PubMed was performed (PROSPERO: CRD42024548245). All articles in English or French were included, and no publication date restrictions were applied. All articles with original data, clinical features and treatment outcomes were included. Two reviewers independently conducted screenings and conflicts were resolved by a third reviewer if necessary. In total, 15 studies (13 case reports and 2 case series) met inclusion criteria, in addition to 1 patient\u2019s case from our own experience, resulting in a total of 18 patients. The majority of our population were male patients (56%) with a median age at diagnosis of 57.5\u2005years (interquartile range 44.8\u201362.8). Most of the patients had absent monoclonal gammopathy (n = 14; 78%), and four (22%) had delayed-onset monoclonal gammopathy. Antihistamines were the most common treatment (n = 18; 100%), followed by anakinra (n = 14; 78%), prednisone (n = 9; 50%), unspecified systemic corticosteroids (n = 8; 44%), omalizumab (n = 8; 44%), colchicine (n = 5; 28%), dapsone (n = 6; 33%), ciclosporin (n = 4; 22%), canakinumab (n = 4; 22%), hydroxychloroquine (n = 2; 11%) and thalidomide (n = 1; 6%). Of the 14 patients treated with anakinra, 93% (n = 13\/14) achieved a complete response. Our findings raise the hypothesis that monoclonal gammopathy may not be an obligate criterion for SS. We propose this as a consideration for future consensus discussions, emphasizing the potential benefits of early recognition and timely interleukin-1 inhibitor therapy to improve patient outcomes.<\/jats:p>","DOI":"10.1093\/ced\/llaf403","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:27:05Z","timestamp":1757330825000},"page":"14-20","source":"Crossref","is-referenced-by-count":1,"title":["Schnitzler syndrome without monoclonal gammopathy: a \u00a0systematic review and case presentation"],"prefix":"10.1093","volume":"51","author":[{"given":"Catherine","family":"Zhu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, McGill University , Montr\u00e9al, QC ,","place":["Canada"]},{"name":"Division of Dermatology, McGill University Health Centre , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-4459","authenticated-orcid":false,"given":"Elvis","family":"Martinez-Jaramillo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-7787","authenticated-orcid":false,"given":"Elena","family":"Netchiporouk","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University Health Centre , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Chergui","sequence":"additional","affiliation":[{"name":"Division of Dermatopathology, McGill University Health Centre , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fein","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre , Montr\u00e9al, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2025122312173521200_llaf403-B1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0190-9622(89)70023-2","article-title":"Chronic urticaria and macroglobulinemia (Schnitzler\u2019s syndrome): report of two cases","volume":"20","author":"Janier","year":"1989","journal-title":"JAAD"},{"key":"2025122312173521200_llaf403-B2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2045-7022-4-41","article-title":"Schnitzler\u2019s syndrome: lessons from 281 cases","volume":"4","author":"de Koning","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"2025122312173521200_llaf403-B3","doi-asserted-by":"crossref","first-page":"1166620","DOI":"10.3389\/fimmu.2023.1166620","article-title":"Case report: Schnitzler-like syndrome without monoclonal gammopathy","volume":"14","author":"Wesselmann","year":"2023","journal-title":"Front Immunol"},{"key":"2025122312173521200_llaf403-B4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14740\/jh800","article-title":"Schnitzler\u2019s syndrome: a diagnostic consideration in evaluating the constellation of monoclonal gammopathy and chronic urticaria","volume":"10","author":"Mamadgi","year":"2021","journal-title":"J Hematol (Brossard)"},{"key":"2025122312173521200_llaf403-B5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5606\/ArchRheumatol.2016.6000","article-title":"Different therapeutic paths (colchicine vs. Anakinra) in two patients with Schnitzler\u2019s syndrome","volume":"31","author":"Bare\u0161i\u0107","year":"2016","journal-title":"Arch Rheumatol"},{"key":"2025122312173521200_llaf403-B6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-5-38","article-title":"The Schnitzler syndrome","volume":"5","author":"Lipsker","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"2025122312173521200_llaf403-B7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.autrev.2014.08.031","article-title":"Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler\u2019s syndrome: a French multicenter study","volume":"13","author":"N\u00e9el","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2025122312173521200_llaf403-B8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"volume-title":"Centre for reviews and dissemination","author":"University of York","key":"2025122312173521200_llaf403-B9"},{"key":"2025122312173521200_llaf403-B10","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2025122312173521200_llaf403-B11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/XEB.0000000000000155","article-title":"The updated Joanna Briggs Institute Model of Evidence-Based Healthcare","volume":"17","author":"Jordan","year":"2019","journal-title":"Int J Evid Based Healthc"},{"key":"2025122312173521200_llaf403-B12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler\u2019s syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"2025122312173521200_llaf403-B13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2133.2000.03394.x","article-title":"Severe course of chronic urticaria, arthralgia, fever and elevation of erythrocyte sedimentation rate: Schnitzler\u2019s syndrome without monoclonal gammopathy?","volume":"142","author":"Husak","year":"2000","journal-title":"Br J Dermatol"},{"key":"2025122312173521200_llaf403-B14","first-page":"366","article-title":"Severe thrombophilia with antiphospholipid syndrome and hyperhomocysteinemia in a patient with Schnitzler\u2019s syndrome","volume":"21","author":"Famularo","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2025122312173521200_llaf403-B15","first-page":"272","article-title":"Schnitzler\u2019s syndrome without monoclonal gammopathy","volume":"85","author":"Varella","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"2025122312173521200_llaf403-B16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2340\/00015555-0233","article-title":"Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG","volume":"87","author":"Treudler","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"2025122312173521200_llaf403-B17","first-page":"1161","article-title":"Schnitzler\u2019s syndrome with biclonal gammopathy successfully treated with hydroxychloroquine and low dose steroids","volume":"26","author":"Lagan\u00e0","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025122312173521200_llaf403-B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4172\/2155-9899.1000265","article-title":"Schnitzler\u2019s syndrome in the absence of a monoclonal gammopathy: a report of two cases","volume":"5","author":"Gladue","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"2025122312173521200_llaf403-B19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/03009742.2015.1071421","article-title":"Delayed development of the IgM paraprotein in Schnitzler\u2019s syndrome","volume":"44","author":"Mulla","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2025122312173521200_llaf403-B20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1203475416657999","article-title":"Schnitzler syndrome without a monoclonal gammopathy: a case report","volume":"20","author":"Urbanski","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"2025122312173521200_llaf403-B21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3349\/ymj.2018.59.1.154","article-title":"A case of Schnitzler\u2019s syndrome without monoclonal gammopathy-associated chronic urticaria treated with anakinra","volume":"59","author":"Ahn","year":"2018","journal-title":"Yonsei Med J"},{"issue":"Suppl. 2","key":"2025122312173521200_llaf403-B22","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2019-eular.4611","article-title":"AB1102 Schnitzler syndrome in the clinical practice of a rheumatologist","volume":"78","author":"Salugina","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"S106","key":"2025122312173521200_llaf403-B23","article-title":"Autoinflammatory syndrome with recurrent neutrophil-rich urticarial exanthema, excessively increased inflammatory markers and response to anakinra in a 77\u2005year-old male patient","volume":"74","author":"Recke","year":"2019","journal-title":"Allergy"},{"key":"2025122312173521200_llaf403-B24","first-page":"38","article-title":"Incomplete Schnitzler syndrome","volume":"28","author":"Henning","year":"2020","journal-title":"Acta Dermatovenerol Croat"},{"key":"2025122312173521200_llaf403-B25","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s10067-020-05501-w","article-title":"Efficacy of interleukin-1 blockade in Schnitzler\u2019s syndrome without detectable monoclonal gammopathy: a case-based review","volume":"40","author":"Bixio","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025122312173521200_llaf403-B26","doi-asserted-by":"crossref","first-page":"100815","DOI":"10.1016\/j.waojou.2023.100815","article-title":"Proposal of a new clinical entity: paraprotein negative IL-1 mediated inflammatory dermatosis (PANID) that may precede Schnitzler syndrome","volume":"16","author":"Fagan","year":"2023","journal-title":"World Allergy Organ J"},{"key":"2025122312173521200_llaf403-B27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13223-023-00819-x","article-title":"Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome","volume":"19","author":"Puxkandl","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025122312173521200_llaf403-B28","first-page":"227","article-title":"The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy","volume":"31","author":"Paulino","year":"2023","journal-title":"Rev Port Imunoalergologia"},{"key":"2025122312173521200_llaf403-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdcr.2024.02.024","article-title":"A case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy","volume":"47","author":"Ghali","year":"2024","journal-title":"JAAD Case Rep"},{"key":"2025122312173521200_llaf403-B30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12891-021-04120-z","article-title":"A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab","volume":"22","author":"Fujita","year":"2021","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf403\/64265187\/llaf403.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/14\/64265187\/llaf403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/14\/64265187\/llaf403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:17:48Z","timestamp":1766510268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/1\/14\/8253926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,15]]},"published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf403","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,15]]}}}